Cationic ammonium surfactants as low dosage hydrate inhibitors

US10435616B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10435616-B2
Application numberUS-201515522906-A
CountryUS
Kind codeB2
Filing dateOct 30, 2015
Priority dateOct 30, 2014
Publication dateOct 8, 2019
Grant dateOct 8, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure relates to anti-agglomerant low dosage hydrate inhibitors that can inhibit the formation of hydrate agglomerants and/or plugs. The anti-agglomerant low dosage hydrate inhibitors can be surfactants. The hydrate inhibitors can be used for inhibiting, retarding, mitigating, reducing, controlling and/or delaying formation of hydrocarbon hydrates, agglomerants of hydrates, and/or plugs. The hydrate inhibitors can be applied to prevent, reduce, and/or mitigate plugging of conduits, pipes, transfer lines, valves, and other places or equipment where hydrocarbon hydrate solids can form. The hydrate inhibitors can be zwitterionic or cationic ammonium surfactants.

First claim

Opening claim text (preview).

What is claimed is: 1. A hydrate inhibitor composition comprising a hydrate-inhibiting effective amount of a compound of Formula (I), or an acid, a free base, a zwitterion, or a salt thereof: wherein R 1 is hydrogen, a C 1 to C 20 substituted or unsubstituted alkyl group, or a C 1 to C 20 substituted or unsubstituted alkenyl group; R 2 is an alkylcarboxyl, or an alkylamido group; R 4 is hydrogen, a C 1 to C 20 substituted or unsubstituted alkyl group, or a C 1 to C 20 substituted or unsubstituted alkenyl group; R 5 is C 10 to C 20 alkyl or —R 50 —NR 6 R 7 , wherein R 50 is C 1 to C 5 alkylene, and R 6 and R 7 are independently C 1 to C 6 alkyl; and R 8 is a C 2 to C 10 substituted or unsubstituted alkylene group. 2. The composition of claim 1 , wherein the substituted alkyl group of R 1 and R 4 has at least one of the —CH 2 — groups in the chain replaced with an ether, an amine, an amide, a carbonyl, or an ester functional group or at least one of the hydrogen atoms attached to a carbon atom of the chain is replaced with a hydroxy, a halo, or an amine group. 3. The composition of claim 2 , wherein the substituted alkyl group of R 1 and R 4 has at least one of the —CH 2 — groups in the chain replaced with an amine. 4. The composition of claim 1 , wherein R 8 is —C 2 H 4 —. 5. The composition of claim 4 , wherein R 1 is C 10 to C 20 alkyl or —R 10 —NR 6 R 7 , wherein R 10 is C 1 to C 5 alkylene, and R 6 and R 7 are independently substituted or unsubstituted C 1 to C 6 alkyl. 6. The composition of claim 1 , wherein R 2 is —R 20 —C(O)O − , wherein R 20 is C 1 to C 4 alkylene. 7. The composition of claim 1 , wherein R 4 is hydrogen. 8. The composition of claim 6 , wherein R 20 is C 2 H 4 , and R 50 is C 3 H 6 . 9. The composition of claim 1 , wherein when the compound is in its salt form, the counterion is selected from the group consisting of a halide, a carboxylate, hydrogen sulfate, dihydrogen phosphate, nitrate, and a combination thereof. 10. The composition of claim 9 , wherein the counterion is an acetate, an acrylate, or a combination thereof. 11. The composition of claim 1 , wherein the composition further comprises a thermodynamic hydrate inhibitor, a kinetic hydrate inhibitor, an anti-agglomerant, or a combination thereof. 12. The composition of claim 1 , wherein the composition further comprises a polar solvent, a nonpolar solvent, or a mixture thereof. 13. A method of inhibiting formation of hydrate agglomerants in a fluid comprising water, a gas, and optionally a liquid hydrocarbon, comprising contacting the fluid with an effective amount of a hydrate inhibitor composition of claim 1 . 14. The method of claim 13 , wherein the effective amount is from about 0.1 to about 10 volume %, based on an amount of water. 15. A hydrate inhibitor composition comprising a hydrate-inhibiting effective amount of: wherein R 11 is C 8 to C 20 alkyl, and R 12 and R 13 are independently C 1 to C 6 alkyl. 16. The composition of claim 15 wherein the compound of Formula 1 is:

Assignees

Inventors

Classifications

  • having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups · CPC title

  • C09K8/52Primary

    Compositions for preventing, limiting or eliminating depositions, e.g. for cleaning · CPC title

  • Hydrates inhibition by using well treatment fluids containing inhibitors of hydrate formers · CPC title

  • having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10435616B2 cover?
This disclosure relates to anti-agglomerant low dosage hydrate inhibitors that can inhibit the formation of hydrate agglomerants and/or plugs. The anti-agglomerant low dosage hydrate inhibitors can be surfactants. The hydrate inhibitors can be used for inhibiting, retarding, mitigating, reducing, controlling and/or delaying formation of hydrocarbon hydrates, agglomerants of hydrates, and/or plu…
Who is the assignee on this patent?
Ecolab Usa Inc
What technology area does this patent fall under?
Primary CPC classification C09K8/52. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).